OBJECTIVE: To compare the Short Test of Mental Status (STMS) with the Montreal Cognitive Assessment (MoCA) for predicting and detecting mild cognitive impairment (MCI). PARTICIPANTS AND METHODS: Participants from the community-based Mayo Clinic Study of Aging (MCSA) (November 24, 2010, through May 19, 2012) and an academic referral Alzheimer's Disease Research Center (ADRC) (March 16, 2015, through September 5, 2018) were analyzed. All participants were evaluated using a standardized neuropsychological battery, and a multidisciplinary consensus diagnosis was assigned. The MCSA and ADRC samples included 313 and 106 stable cognitively normal (CN) participants, 72 and 8 CN participants at baseline who developed incident MCI or dementia, 114 and 96 participants with prevalent MCI, and 25 and 132 participants with dementia, respectively. RESULTS: There were no statistically significant differences between the 2 tests in 6 of 7 diagnostic comparisons across academic referral and community populations. The STMS had a better area under the curve (0.90; 95% CI, 0.87-0.93) for differentiating prevalent MCI from CN participants in the MCSA cohort compared with the MoCA cohort (0.85; 95% CI, 0.81-0.89; P=.01). In addition, 53% of the stable CN participants (222 of 419) scored less than 26 on the MoCA, with specificity of 47% for diagnosing prevalent MCI. CONCLUSION: We provide evidence that the STMS performs similarly to the MoCA in a variety of settings and neurodegenerative syndromes. These results suggest that the current recommended MoCA cutoff score may be overly sensitive, consistent with previous studies. We also provide a conversion table for comparing the 2 cognitive tests.
OBJECTIVE: To compare the Short Test of Mental Status (STMS) with the Montreal Cognitive Assessment (MoCA) for predicting and detecting mild cognitive impairment (MCI). PARTICIPANTS AND METHODS: Participants from the community-based Mayo Clinic Study of Aging (MCSA) (November 24, 2010, through May 19, 2012) and an academic referral Alzheimer's Disease Research Center (ADRC) (March 16, 2015, through September 5, 2018) were analyzed. All participants were evaluated using a standardized neuropsychological battery, and a multidisciplinary consensus diagnosis was assigned. The MCSA and ADRC samples included 313 and 106 stable cognitively normal (CN) participants, 72 and 8 CN participants at baseline who developed incident MCI or dementia, 114 and 96 participants with prevalent MCI, and 25 and 132 participants with dementia, respectively. RESULTS: There were no statistically significant differences between the 2 tests in 6 of 7 diagnostic comparisons across academic referral and community populations. The STMS had a better area under the curve (0.90; 95% CI, 0.87-0.93) for differentiating prevalent MCI from CN participants in the MCSA cohort compared with the MoCA cohort (0.85; 95% CI, 0.81-0.89; P=.01). In addition, 53% of the stable CN participants (222 of 419) scored less than 26 on the MoCA, with specificity of 47% for diagnosing prevalent MCI. CONCLUSION: We provide evidence that the STMS performs similarly to the MoCA in a variety of settings and neurodegenerative syndromes. These results suggest that the current recommended MoCA cutoff score may be overly sensitive, consistent with previous studies. We also provide a conversion table for comparing the 2 cognitive tests.
Authors: Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve Journal: Neurocase Date: 2020-06-30 Impact factor: 0.881
Authors: Nick Corriveau-Lecavalier; Wentao Li; Vijay K Ramanan; Daniel A Drubach; Gregory S Day; David T Jones Journal: J Neurol Date: 2022-03-01 Impact factor: 6.682
Authors: Nick Corriveau-Lecavalier; Eva C Alden; Nikki H Stricker; Mary M Machulda; David T Jones Journal: Arch Clin Neuropsychol Date: 2022-08-23 Impact factor: 3.448
Authors: Nikki H Stricker; Emily S Lundt; Sabrina M Albertson; Mary M Machulda; Shehroo B Pudumjee; Walter K Kremers; Clifford R Jack; David S Knopman; Ronald C Petersen; Michelle M Mielke Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: David J Sandness; Stuart J McCarter; Lucas G Dueffert; Paul W Shepard; Ashley M Enke; Julie Fields; Michelle M Mielke; Bradley F Boeve; Michael H Silber; Erik K St Louis Journal: Sleep Date: 2022-04-11 Impact factor: 6.313
Authors: Petrice M Cogswell; Jonathan Graff-Radford; Lincoln I Wurtz; Neill R Graff-Radford; Derek R Johnson; Christopher H Hunt; Jeffrey L Gunter; Jeremy K Cutsforth-Gregory; David T Jones; Benjamin D Elder; John Huston Iii; Clifford R Jack Journal: Neuroimage Clin Date: 2020-10-28 Impact factor: 4.881
Authors: Petrice M Cogswell; Heather J Wiste; Matthew L Senjem; Jeffrey L Gunter; Stephen D Weigand; Christopher G Schwarz; Arvin Arani; Terry M Therneau; Val J Lowe; David S Knopman; Hugo Botha; Jonathan Graff-Radford; David T Jones; Kejal Kantarci; Prashanthi Vemuri; Bradley F Boeve; Michelle M Mielke; Ronald C Petersen; Clifford R Jack Journal: Neuroimage Date: 2020-10-06 Impact factor: 6.556
Authors: Clifford R Jack; Heather J Wiste; Stephen D Weigand; Terry M Therneau; Val J Lowe; David S Knopman; Hugo Botha; Jonathan Graff-Radford; David T Jones; Tanis J Ferman; Bradley F Boeve; Kejal Kantarci; Prashanthi Vemuri; Michelle M Mielke; Jennifer Whitwell; Keith Josephs; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Ronald C Petersen Journal: Brain Date: 2020-10-01 Impact factor: 13.501